InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Thursday, 08/15/2013 3:16:01 PM

Thursday, August 15, 2013 3:16:01 PM

Post# of 430335
Dr. Woodcock your words will come back to haunt you...LOL!!!

http://www.regulations.gov/#!documentDetail;D=FDA-2013-P-0025-0003

Read pages 5 and 6, Janet explains how the FDA does it...

Background:
-Vascepa has no exclusivity after a year
-NDA letter had no reason why an Ad Com wasn't required
-The drug this letter is refering to is a mix that's already been approved before.

Must Read and then laugh.... a lot!

Williams

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News